Results 11 to 20 of about 4,240 (196)

Zollinger-Ellison syndrome: Revelation of the gastrinoma triangle [PDF]

open access: yesRadiology Case Reports, 2015
Zollinger-Ellison syndrome is a complex condition in which one or more tumors form in the patient's pancreas or upper duodenum. These tumors, called gastrinomas, secrete excessive amounts of gastrin, and almost all develop ulcers.
Rong-Hsin Yang, MD, Yum-Kung Chu, MD
doaj   +3 more sources

Esophageal Perforation in Zollinger–Ellison Syndrome: A Scoping Review of Management and Outcomes [PDF]

open access: yesJGH Open
Esophageal perforation in Zollinger–Ellison syndrome (ZES) is an exceedingly rare and life‐threatening manifestation of gastrinoma‐related acid hypersecretion.
Agostino Fernicola   +8 more
doaj   +3 more sources

Zollinger–Ellison syndrome in a 12-year-old child

open access: yesJournal of Indian Association of Pediatric Surgeons, 2017
The syndrome described by Zollinger and Ellison in 1955 is a rare clinical entity which is even rarer in children. This report describes a 12-year-old boy who presented with refractory peptic ulcer disease which was finally diagnosed to be due to a ...
Abir Lal Nath   +5 more
doaj   +3 more sources

Zollinger Ellison Syndrome in a Patient with Multiple Endocrine Neoplasia Type 1: A Classic Presentation [PDF]

open access: yesCase Reports in Gastrointestinal Medicine, 2019
Zollinger Ellison Syndrome (ZES) is characterized by a wide spectrum of conditions including severe gastroesophageal reflux disease, peptic ulcer disease, watery diarrhea, and weight loss.
Ishani Shah   +2 more
doaj   +3 more sources

Case Report: PRRT in a patient with Zollinger-Ellison syndrome. The management of gastrointestinal complications [PDF]

open access: yesFrontiers in Oncology
Zollinger-Ellison Syndrome (ZES) is a rare condition characterized by excessive gastric acid secretion due to gastrin-producing neuroendocrine tumors.
Martina Di Franco   +7 more
doaj   +4 more sources

Pharmacotherapy of Zollinger–Ellison syndrome [PDF]

open access: yesExpert Opinion on Pharmacotherapy, 2013
The role of pharmacotherapy in the management of patients with Zollinger-Ellison syndrome (ZES) is often equated with the medical management of acid hypersecretion. However, pharmacotherapy is also increasingly involved in the other management areas of these patients.This paper reviews the role of pharmacotherapy in all aspects of the management of ...
Tetsuhide Itô   +2 more
exaly   +5 more sources

Primary Hepatic Gastrinoma as an Unusual Manifestation of Zollinger-Ellison Syndrome [PDF]

open access: yesCase Reports in Gastroenterology, 2012
We report a rare case of primary hepatic gastrinoma. A 77-year-old woman exhibited continuous watery diarrhea for 8 months and weight loss.
Hideaki Naoe   +14 more
doaj   +3 more sources

Radiological Features of Zollinger–Ellison Syndrome: A Report of Two Cases [PDF]

open access: yesIndian Journal of Radiology and Imaging, 2022
Hypersecretion of gastrin from duodenal or pancreatic gastrinomas results in a rare clinical entity called Zollinger–Ellison syndrome (ZES). It mostly presents with abdominal pain and diarrhea.
Thara Pratap   +5 more
doaj   +2 more sources

Zollinger-Ellison Syndrome - review

open access: yesJournal of Education, Health and Sport, 2022
Introduction and purpose Zollinger-Ellison syndrome (ZES) is a constellation of symptoms that includes gastric ulcer, gastroesophageal reflux disease (GERD), and chronic diarrhea.
Jakub Metelski   +4 more
doaj   +3 more sources

Postsurgical Presentation of Zollinger-Ellison Syndrome After Resection of Endometrioid Neuroendocrine Tumor. [PDF]

open access: yesACG Case Rep J, 2021
Zollinger-Ellison syndrome is a functional neuroendocrine tumor with inappropriate gastrin secretion and hyperchlorhydria causing severe peptic ulcer disease and chronic diarrhea.
Almuhaidb A, Davidson NO.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy